{"transactions":[{"id":1314015,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:08:03.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares  on each of 1/1/25, 1/1/26 and 1/1/27."}],"balance_after":7050,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001062993-25-000236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299325000236/form4.xml","form_type":"4"}},{"id":1513999,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T20:26:53.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2023.  This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26."}],"balance_after":7323,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":7323},"source":{"system":"sec-edgar","filing":"0001062993-24-010455","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010455/form4.xml","form_type":"4"}},{"id":1708961,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:48:32.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":9291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":48629,"source":{"system":"sec-edgar","filing":"0001062993-23-022644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323022644/form4.xml","form_type":"4"}},{"id":1808143,"issuer":{"id":108806,"kind":"organization","name":"RVL Pharmaceuticals plc","symbol":"RVLP"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-14T17:35:04.000Z","date":"2023-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":12000,"price":0.49,"value":5880.0,"ownership":{"direct":true},"balance_after":112557,"source":{"system":"sec-edgar","filing":"0001104659-23-091548","document":"tm2323760-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739426/000110465923091548/tm2323760-1_4seq1.xml","form_type":"4"}},{"id":1831411,"issuer":{"id":108806,"kind":"organization","name":"RVL Pharmaceuticals plc","symbol":"RVLP"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-07-11T21:15:22.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units."}],"balance_after":124557,"source":{"system":"sec-edgar","filing":"0001104659-23-080116","document":"tm2321087-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739426/000110465923080116/tm2321087-1_4seq1.xml","form_type":"4"}},{"id":2058627,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-09T21:33:11.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000721/form4.xml","form_type":"4"}},{"id":2058626,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:33:11.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":27613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":39338,"source":{"system":"sec-edgar","filing":"0001062993-23-000721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000721/form4.xml","form_type":"4"}},{"id":2186516,"issuer":{"id":108806,"kind":"organization","name":"RVL Pharmaceuticals plc","symbol":"RVLP"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-12T16:07:32.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units."}],"balance_after":84557,"source":{"system":"sec-edgar","filing":"0001104659-22-090049","document":"tm2222999-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739426/000110465922090049/tm2222999-7_4seq1.xml","form_type":"4"}},{"id":2469626,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-17T02:17:32.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":7062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."}],"balance_after":7062,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7062},"source":{"system":"sec-edgar","filing":"0001437749-21-028836","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028836/rdgdoc.xml","form_type":"4"}},{"id":2469625,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-17T02:17:32.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":11725,"source":{"system":"sec-edgar","filing":"0001437749-21-028836","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028836/rdgdoc.xml","form_type":"4"}},{"id":2912039,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T22:31:58.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23."}],"balance_after":6850,"derivative":{"exercise_price":8.06,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0000914190-21-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000009/edgar.xml","form_type":"4"}},{"id":2912038,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:31:58.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0000914190-21-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000009/edgar.xml","form_type":"4"}},{"id":3336504,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-18T22:13:40.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":5568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the \"Option\") in respect of the service by Ms. Lask as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21."}],"balance_after":5568,"derivative":{"exercise_price":8.57,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":5568},"source":{"system":"sec-edgar","filing":"0000914190-19-000508","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419019000508/edgar.xml","form_type":"4"}},{"id":3336503,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-18T22:13:40.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":3227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2019, the Company granted 3,227 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Ms. Lask in respect of her services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). The Restricted Stock vests 6 months following the grant date."}],"balance_after":3477,"source":{"system":"sec-edgar","filing":"0000914190-19-000508","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419019000508/edgar.xml","form_type":"4"}},{"id":3414881,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-13T20:32:52.000Z","date":"2019-09-11","kind":"purchase","acquired":true,"shares":250,"price":6.45,"value":1612.5,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0000914190-19-000377","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419019000377/edgar.xml","form_type":"4"}},{"id":3542118,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-02T20:05:02.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":86546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 8, 2019, the Company granted to Ms. Lask an option to purchase 86,546 shares of common stock of the Company, of which one-third vested immediately upon the grant date, one-third will vest on the first anniversary of the grant date, and the remaining one-third will vest on the second anniversary of the grant date."}],"balance_after":86546,"derivative":{"exercise_price":0.58,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":86546},"source":{"system":"sec-edgar","filing":"0000914190-19-000138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419019000138/edgar.xml","form_type":"4/A","original_submission_date":"2019-02-12"}},{"id":3662649,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-12T21:31:04.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":70817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 8, 2019, the Company granted to Ms. Lask an option to purchase 70,817 shares of common stock of the Company, of which one-third vested immediately upon the grant date, one-third will vest on the first anniversary of the grant date, and the remaining one-third will vest on the second anniversary of the grant date."}],"balance_after":70817,"derivative":{"exercise_price":0.58,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":70817},"source":{"system":"sec-edgar","filing":"0000914190-19-000023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419019000023/edgar.xml","form_type":"4"}}]}